Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20226083rdf:typepubmed:Citationlld:pubmed
pubmed-article:20226083lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:20226083lifeskim:mentionsumls-concept:C0013216lld:lifeskim
pubmed-article:20226083lifeskim:mentionsumls-concept:C0007131lld:lifeskim
pubmed-article:20226083lifeskim:mentionsumls-concept:C1335648lld:lifeskim
pubmed-article:20226083lifeskim:mentionsumls-concept:C0752046lld:lifeskim
pubmed-article:20226083lifeskim:mentionsumls-concept:C0242792lld:lifeskim
pubmed-article:20226083pubmed:dateCreated2010-4-19lld:pubmed
pubmed-article:20226083pubmed:abstractTextThe ribonucleotide reductase M1 (RRM1) gene encodes the regulatory subunit of ribonucleotide reductase, the molecular target of gemcitabine. The overexpression of RRM1 mRNA in tumor tissues is reported to be associated with gemcitabine resistance. Thus, single nucleotide polymorphisms (SNPs) of the RRM1 gene are potential biomarkers of the response to gemcitabine chemotherapy. We investigated whether RRM1 expression in peripheral blood mononuclear cells (PBMCs) or SNPs were associated with clinical outcome after gemcitabine-based chemotherapy in advanced non-small cell lung cancer (NSCLC) patients.lld:pubmed
pubmed-article:20226083pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20226083pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20226083pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20226083pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20226083pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20226083pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20226083pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20226083pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20226083pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20226083pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20226083pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20226083pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20226083pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20226083pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20226083pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20226083pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20226083pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20226083pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20226083pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20226083pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20226083pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20226083pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20226083pubmed:languageenglld:pubmed
pubmed-article:20226083pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20226083pubmed:citationSubsetIMlld:pubmed
pubmed-article:20226083pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20226083pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20226083pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20226083pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20226083pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20226083pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20226083pubmed:statusMEDLINElld:pubmed
pubmed-article:20226083pubmed:issn1756-8722lld:pubmed
pubmed-article:20226083pubmed:authorpubmed-author:OkSSlld:pubmed
pubmed-article:20226083pubmed:authorpubmed-author:WangZhenZlld:pubmed
pubmed-article:20226083pubmed:authorpubmed-author:HuangYingYlld:pubmed
pubmed-article:20226083pubmed:authorpubmed-author:ChengHuaHlld:pubmed
pubmed-article:20226083pubmed:authorpubmed-author:SongDongDlld:pubmed
pubmed-article:20226083pubmed:authorpubmed-author:ChenZhi-HongZ...lld:pubmed
pubmed-article:20226083pubmed:authorpubmed-author:WuYi-LongYLlld:pubmed
pubmed-article:20226083pubmed:authorpubmed-author:GuoAi-LinALlld:pubmed
pubmed-article:20226083pubmed:authorpubmed-author:ZhangXu-ChaoX...lld:pubmed
pubmed-article:20226083pubmed:authorpubmed-author:YanHong-HongH...lld:pubmed
pubmed-article:20226083pubmed:issnTypeElectroniclld:pubmed
pubmed-article:20226083pubmed:volume3lld:pubmed
pubmed-article:20226083pubmed:ownerNLMlld:pubmed
pubmed-article:20226083pubmed:authorsCompleteYlld:pubmed
pubmed-article:20226083pubmed:pagination10lld:pubmed
pubmed-article:20226083pubmed:dateRevised2010-9-30lld:pubmed
pubmed-article:20226083pubmed:meshHeadingpubmed-meshheading:20226083...lld:pubmed
pubmed-article:20226083pubmed:meshHeadingpubmed-meshheading:20226083...lld:pubmed
pubmed-article:20226083pubmed:meshHeadingpubmed-meshheading:20226083...lld:pubmed
pubmed-article:20226083pubmed:meshHeadingpubmed-meshheading:20226083...lld:pubmed
pubmed-article:20226083pubmed:meshHeadingpubmed-meshheading:20226083...lld:pubmed
pubmed-article:20226083pubmed:meshHeadingpubmed-meshheading:20226083...lld:pubmed
pubmed-article:20226083pubmed:meshHeadingpubmed-meshheading:20226083...lld:pubmed
pubmed-article:20226083pubmed:meshHeadingpubmed-meshheading:20226083...lld:pubmed
pubmed-article:20226083pubmed:meshHeadingpubmed-meshheading:20226083...lld:pubmed
pubmed-article:20226083pubmed:meshHeadingpubmed-meshheading:20226083...lld:pubmed
pubmed-article:20226083pubmed:meshHeadingpubmed-meshheading:20226083...lld:pubmed
pubmed-article:20226083pubmed:meshHeadingpubmed-meshheading:20226083...lld:pubmed
pubmed-article:20226083pubmed:meshHeadingpubmed-meshheading:20226083...lld:pubmed
pubmed-article:20226083pubmed:meshHeadingpubmed-meshheading:20226083...lld:pubmed
pubmed-article:20226083pubmed:meshHeadingpubmed-meshheading:20226083...lld:pubmed
pubmed-article:20226083pubmed:meshHeadingpubmed-meshheading:20226083...lld:pubmed
pubmed-article:20226083pubmed:meshHeadingpubmed-meshheading:20226083...lld:pubmed
pubmed-article:20226083pubmed:meshHeadingpubmed-meshheading:20226083...lld:pubmed
pubmed-article:20226083pubmed:meshHeadingpubmed-meshheading:20226083...lld:pubmed
pubmed-article:20226083pubmed:meshHeadingpubmed-meshheading:20226083...lld:pubmed
pubmed-article:20226083pubmed:meshHeadingpubmed-meshheading:20226083...lld:pubmed
pubmed-article:20226083pubmed:year2010lld:pubmed
pubmed-article:20226083pubmed:articleTitleRRM1 single nucleotide polymorphism -37C-->A correlates with progression-free survival in NSCLC patients after gemcitabine-based chemotherapy.lld:pubmed
pubmed-article:20226083pubmed:affiliationGuangdong Lung Cancer Institute, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.lld:pubmed
pubmed-article:20226083pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:20226083pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:6240entrezgene:pubmedpubmed-article:20226083lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:20226083lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:20226083lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:20226083lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:20226083lld:pubmed